Electronic Health Records (EHR) containing large amounts of patient data present both opportunities and challenges to industry, policy makers, and researchers. These data, when extracted and analyzed effectively, can reveal critical factors that can improve clinical practices and decisions. However, the inherently complex, heterogeneous and rapidly evolving nature of these data make them extremely difficult to analyze effectively. In addition, Protected Health Information (PHI) containing sensitive yet valuable information for clinical research must first be anonymized. In this paper we identify current challenges with obtaining and preprocessing information from EHR. We then present a comprehensive, efficient "pipeline" for extracting, deidentifying, and standardizing EHR data. We demonstrate the use of this pipeline, based on software from EPIC Systems, in analysing chronic kidney disease, prostate cancer, and cardiovascular disease. We also address challenges associated with temporal laboratory time series data and natural text data and develop a novel approach for clustering irregular Multivariate Time Series (MTS). The pipeline organizes data into a structured, machine-readable format which can be effectively applied in clinical research studies to optimize processes, personalize care, and improve quality, and outcomes.
INTRODUCTION
Electronic health record (EHR) plays an important role in advancing clinical and operational processes. Although early clinical medical records first appeared in 1600 BC, it was not until 1900 that it was put into regular use (Gillum, 2013) . The launch of the 10year-effort to create a national electronic medical record system by the United State government in 2004 helped fuel its rapid adoption and medical advance (Gunter and Terry, 2005) . As of 2015, 80 percent of U.S. hospitals had adopted a basic electronic health record keeping system (Henry et al., 2016) . The value of EHR data is increasingly recognized by health care organizations and government. Its utilizations significantly changed the patient-clinic interaction process (Asan et al., 2015) .
Data-driven healthcare has the potential to revolutionize care delivery while reducing costs. However, for policymakers, practitioners, and researchers to take full advantage, several challenges must be addressed: 1) Extraction and coding methods for EHR data must be strategically designed considering issues related to data quantity, quality, interoperability, and patient confidentiality; 2) Standardization of clinical terminologies is essential in facilitating interoperability among EHR systems and allows for multi-site comparative effectiveness studies; 3) Effective methods for mining longitudinal health data common in EHR are critical for revealing disease progression, treatment patterns, and patient similarities, all of which play important roles in clinical decision support and treatment improvement; 4) Advanced machine learning techniques are necessary for early detection and prognosis of disease and identifying critical factors that impact patient outcome; 5) Practical intervention strategies must be developed to address healthcare disparities in rural and remote areas with lack of resources and access.
In this study, we focus on tackling the first three challenges by 1) developing a framework for identifying and extracting key clinical features from structured and unstructured data, 2) developing a concept standardization procedure among the multitude of available clinical terminologies, and 3) implementing unsupervised learning algorithms for characterizing patient treatment outcomes based on longitudinal data. These critical data pre-processing steps allow us to better understand patient characteristics and treatment patterns. We can subsequently build outcome predictive models to identify critical features that contribute to variance in treatment outcomes. Best practices can be developed based on these factors and can help hospitals to redesign and implement evidence-based treatment plans to achieve better outcome (Lee et al., 2016) .
LITERATURE REVIEW
It is challenging to establish an efficient data extraction schema for EHR due to the complexity of data and lack of data standards. A common task in EHR is case detectionidentifying a cohort of patients with a certain condition or symptom. Coded data such as International Classification of Disease (ICD) codes are often not sufficient or accurate (Birman-Deych et al., 2005) . Informatics approaches combining structured EHR data with narrative text data achieve better performance (Li et al., 2008) . Key clinical items can be extracted from narrative texts with simple methods such as pattern matching using regular expression (Long, 2005 , Turchin et al., 2006 , full or partial parsing based on morpho-semantems (Baud et al., 1998) , and syntactic and semantic analysis (Jain and Friedman, 1997) . Recently, more complex statistical and rule-based machine learning approaches (Bashyam and Taira, 2005) have been developed to tackle this challenge. Biomedical Named Entity Recognition (NER) -the "task of identifying words and phrases in free text that belong to certain classes of interest" (Settles, 2004) , allows users to identify key clinical concepts such as physician visits, referrals, dietary management, and suspected problems normally not present in structured data tables.
Negation detection, which identifies the negative sense of a concept, is another essential task accompanying NER, since the presence of negations can yield false-positive detections because medical personnel are trained to include pertinent negatives in their reports (Mutalik et al., 2001) . It has been achieved through rule-based / syntactic parsing (Chapman et al., 2001 , Gindl et al., 2008 , Elkin et al., 2005 and machine learning (De Bruijn et al., 2011 , Díaz et al., 2012 , Goldin and Chapman, 2003 approaches.
Once patient information is extracted, data security and confidentiality must be ensured through de-identification steps. According to Health Insurance Portability and Accountability Act (HIPAA), patients' Protected Health Information (PHI) must be de-identified or anonymized for commercial and research interest. PHI exists in both structured and unstructured clinical records (Zikopoulos and Eaton, 2011) . This includes patient names, addresses, phone numbers, etc. Manual and rule-based or lexicon-based methods have been used to achieve PHI de-identification (Sweeney, 1996 , Ruch et al., 2000 , Taira et al., 2002 , but they are extremely time-consuming and can be inaccurate. Machine learning approaches have also been developed (Sibanda and Uzuner, 2006, Wellner et al., 2007) . However, due to the complexity of data schemas and the heterogeneity of data structures, it is very challenging to detect PHI with high sensitivity.
Because EHR data include various types of records for patients, it is extremely difficult to analyze all these data without data standardization. In addition, since these data are recorded by different hospital staff members at various provider sites, data heterogeneity becomes a major issue due to the significant practice variation in style of reporting, use of terminologies, and descriptive content.
Tackling the problem of data heterogeneity is essential for conducting predictive analytics using artificial intelligence. Many clinical records in the EHR adhere to different terminology systems and can cause problems such as data redundancy and inconsistency, hindering the performance of automated machine learning models. To establish interoperability among various naming systems, standardization of data is necessary. In our previous work, (Lee et al., 2016) , clinical concepts were standardized by a concept mapping system which links concepts describing diagnosis, laboratory, and medications to the standardized SNOMED-CT terminologies.
Standardization of terminologies not only facilitates the analysis of EHR data but can also increase the efficiency of operations and information sharing, thereby facilitating knowledge transfer and reducing practice variance among health care organizations.
Analyzing longitudinal clinical data recorded during care delivery is challenging due to their incompleteness and non-uniformness. Identification of subgroups of patients who experience symptoms with greater or lesser severity (Miaskowski et al., 2006) or respond to treatment procedures differently may reveal critical risk or treatment factors that impact patient outcome. Laboratory and vitals measurements before, during, and after treatment may act as markers of disease severity (Wells et al., 2013) and characterize recovery process. Uncovering patient clusters also have prognostic significanceby constructing cluster-based clinical event predictive models, one can achieve superior performance when compared to treating all patient episodes as a single group (Marlin et al., 2012) . However, laboratory and vitals in the form of time series often exhibit different length and frequency due to different syndromes and schedules for different patients. Thus, conventional clustering algorithms aiming to identify patient subgroups cannot be applied directly. Pre-processing methods such as interpolation (Lee et al., 2000, Kreindler and Lumsden, 2016) and resampling (Carlstein, 1992) can normalize time series data. Alternatively, clustering algorithms have been customized for variable-length time series. They utilize a variety of similarity (distance) measures such as Dynamic Time Warping (DTW) (Sakoe, 1971), Soft-DTW (Cuturi and Blondel, 2017) , Global Alignment Kernel (GAK) (Cuturi et al., 2007) , and Time-Warp Edit Distance (TWED) (Marteau, 2009) .
While some disease severity can be characterized by a single type of laboratory measurementfor exampleserum cholesterol levels can be used to characterize conditions of patients with hyperlipidemia (Wells et al., 2013) , others can be better defined by multiple laboratory measurement time series. For instance, systolic blood pressure and diastolic blood pressure should both be considered for patients with hypertension. Clustering approaches for such Multivariate Time Series (MTS) (Brockwell et al., 2002) are limited. Existing PCA-based (Singhal and Seborg, 2005) , Hidden Markov Model (HMM)based , partition-based (Liao, 2007) , and model-based approaches (Košmelj and Batagelj, 1990, Ramoni et al., 2002) have been applied to a variety of fields including chemistry and manufacturing, but have not been utilized in clinical settings. This is likely due to the irregularity of clinical time series. As far as we are concerned, clustering approaches have not been developed for MTS with irregular intervals and unequal lengths. We will refer to these MTS as "irregular MTS" throughout this paper.
METHODS

Data Extraction Methods from EPIC EHR Database
Kaiser Permanente (KP) uses the Clarity module to transform data from EPIC's operational database into a relational form for reporting. Clarity database from the KP's HealthConnect EHR system stores patient data in over 7,000 tables with over 60,000 columns and update daily (Waitman et al., 2011) . The EPIC Clarity database has recently been imported to Oracle Exadata for performance improvement. Structured Query Language (SQL) written in Oracle SQL Developer is the primary programming language used to access the database.
Extract Patient Cohort Characterized by Disease or Symptoms
To extract patient data with certain disease or symptoms, we first utilize the ICD-9 / ICD-10 diagnosis codes. A Patient ID is selected from the problem list table if its corresponding record contains the target diagnosis code(s). In many cases, however, diagnosis codes are not well-maintained, so it is necessary to utilize billing information, laboratory data or narratives in clinical notes for more accurate case detection. This can be done using semantic matching of key terms describing medical conditions. The extracted patient IDs are then used to link to the other data tables to extract the relevant information. Table 1 lists the types and coverages of information extracted. Although most demographics, medications, billing, procedures, and co-existing conditions can be found directly from structured data tables, encounter-level data containing physician visits and referrals, dietary management, and suspected problems must be extracted from the clinical notes table. 
Extract Patient Cohort Characterized by Treatment Features
To extract patient data with certain treatment features (i.e. procedures, prescriptions, laboratory measurements), we must first identify all the possible vocabularies that represent the treatment features. These vocabularies are compiled into a list and are used to index the billing / laboratory / medication tables to select the target patient IDs. Alternatively, regular expressions can be used to represent groups of vocabularies to create more succinct queries.
Table Partitioning and Temporary Views
In many data extraction tasks, the targeted patient cohort contains millions of patient records amounting to terabytes of data. In such cases, table partitions are created to retrieve data by chunks and reduce local storage loads. Temporary views are used to reduce server loads.
PHI Encryption for Structured Data and Narrative Texts
The SHA-256 Cryptographic Hash Algorithm is used to encrypt Patient IDs contained in every data record. For unstructured free-text data, we apply the transition-based parsing model implemented in the Python spaCy package (Honnibal and Johnson, 2015) to detect and de-identify PHI in clinical notes. We identify and replace the following types of entities: PERSON, NORP, ORG, and GPE. These entities cover patient names, nationalities, organizations, and addresses. In addition, we include a regular expression-based filter to replace Telephone numbers as well.
Information Extraction from Narrative Clinical Texts
We develop an end-to-end "pipeline" (software from EPIC Systems coded to process data into a more usable form) for extracting key clinical features from narrative documents. These features are then filtered by negation detection and remaining features are mapped to standardized SNOMED-CT terminology. Figure 1 shows the feature extraction pipeline from clinical text. We implement the content summarization module based on the TextRank algorithm (Mihalcea and Tarau, 2004) . We apply the CLiNER concept recognition model (Boag et al., 2018) to extract key clinical features including problems, procedures, and tests. An improved Negex (Chapman et al., 2001) algorithm is then used to filter features within a negated context. We then proceed in one of two directions: 1) utilize MetaMap to map the consolidated features to the SNOMED-CT terminology system and filter out features that are not mapped. The hierarchical structure of SNOMED-CT and MetaMap are utilized to remove general concepts (e.g. "Body structure", "Clinical finding", "Biological agent") that are situated at the top two levels in the SNOMED-CT concept tree; 2) utilize the terminology mapping system developed in Section 3.2 to directly map these concepts to SNOMED-CT. These standardized concepts can be consolidated into input features that could be directly input into machine learning algorithms for knowledge discovery.
Data Interoperability with Medical Terminology Mapping
We apply the concept mapping system described in (Lee et al., 2016) to standardize all labs and medications data. For data related to procedures, we design a similar approach. Instead of mapping the top scoring UMLS Metathesaurus concepts to either RxNorm or LOINC terms separately, we attempt to map the UMLS concepts to both RxNorm and LOINC because procedures can contain both medication and lab-related information (Figure 2) . We then select the mapping with the higher matching score of the two. This process removes redundancies in the data and produces a condensed feature list which can be used for machine learning tasks. 
Characterizing Patient Treatment Outcomes based on Longitudinal Laboratory Measurements
In order to characterize patient conditions using multiple laboratory measurements in the form of MTS, we develop a novel clustering approach for irregular MTS based on existing distance metrics for variable-length time series. DTW, soft-DTW, and GAK are used to calculate the pairwise distances between variable-length univariate time series. An aggregation function is then applied to the distance between all pairs of corresponding univariate time series composing the MTS. This produces a pairwise distance matrix representing the similarity between each pair of patients. Clustering based on a pairwise matrix can be done using hierarchical or medoid-based clustering algorithms, because it is difficult to determine the length of the cluster centers when using partitionbased clustering algorithms such as K-means (Liao, 2007) . In this study, we apply the K-medoids (Park and Jun, 2009 ) clustering algorithm to the distance matrices.
Here, we describe the entire clustering process using the Global Alignment Kernel (GAK) metrics (Cuturi et al., 2007) as an example. GAK can be used to quantify the similarity between two time series of varying lengths. It is positive definite, rapidly computed, and operates on the whole spectrum of costs of alignments and thus contains a richer statistics than DTW, which considers only the minimum of the set of costs (Cuturi et al., 2007) . GAK distance is equal to the sum of the exponentiated and sign changed similarities of every alignment pairs:
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Weights are assigned to each laboratory time series depending on their importance in characterizing patient conditions. Alternatively, mean, median, or the sum function could be used as the aggregation function. The aggregated distance represents an alignment score over each pair of univariate time series and provides a holistic similarity measure for the pair of MTS. In this study, we compare the performance of GAK metrics to that of DTW and soft-DTW when used in MTS clustering.
CASE STUDIES
We demonstrate the use of our EHR information extraction and pre-processing pipeline for three different types of disease cases: prostate cancer, chronic kidney diseases, and cardiovascular diseases.
Patients with Prostate Cancer
Prostate cancer is the most frequently diagnosed cancer in 105 countries and the fifth leading cause of cancer death in men (Bray et al., 2018) . It is estimated that there will be 174,650 new cases of prostate cancer in the U.S. in 2019 with an associated 31,620 deaths (Siegel et al., 2019) . Early prostate cancer detection has been achieved through prostatespecific antigen (PSA) test and biopsy of tissue removed during prostatectomy or at autopsy (Bray et al., 2018) . Through mathematical modelling, (Etzioni et al., 2008) concluded that under the assumption that stage shift implies survival shift-which motivates early detection of cancer, PSA screening likely explains half or more of the mortality reduction observed in the U.S. since the early 1990s. EHR provides long-term tracking of patient PSA test results. These longitudinal data can be extracted using the lab component IDs or names of the test procedure. The rate of increase in PSA level, often represented using PSA doubling time or PSA velocity, has been widely used in the management of prostate cancer (Ng et al., 2009 ).
Information Extraction from EPIC EHR Database
The extracted dataset covers 98,806 patients with the ICD-9 code 790.93 or ICD-10 code 97.20, "elevated prostate specific antigen (PSA)". This dataset spans the years 1997-2018 and is composed of patient-level data (70Mb), problem lists (384Mb), medications (7.3Gb), billing (167Mb), laboratory orders (10Gb), and clinical notes (46.1Gb), totalling 64.02 Gigabytes. Patient IDs were successfully encrypted using SHA-256 encryption. PHI including patient names, addresses, institutions, age, phone numbers, and email addresses were detected and encrypted into dummy tokens. We applied the clinical concept extraction system on a subset of patients treated with radioactive seed implants. An additional 2,194 standardized clinical features were extracted from their clinical notes, including "Chronic pain syndrome", "Placement of stent", "Nerve conduction testing", "Vascular Calcification", "Overweight", "Obstructive sleep apnea syndrome", "Neoplasm, metastatic", and "Lithotripsy", etc.
Patient PSA laboratory test results were used as indicators of disease severity. PSA records were retrieved by the following method: 1) component IDs for lab records matching the query string "%PSA%" were retrieved; 2) PSA-irrelevant lab components were discarded, leaving 10 unique component IDs corresponding to "PSA-screening", "PSAmonitoring", "PSA", "PSA FREE", "PSA % FREE", "PSA, external result", "PSA, MHS", "PSA with reflex FPSA, external result", "PSA, screening", and "PSA, cancer monitoring"; 3) "PSA FREE" and "PSA % FREE" were removed from the list of candidate components since free PSA is reported as a percentage of the total that is not protein bound, i.e., free. The higher the free PSA, the lower the likelihood of cancer; 4) PSA lab records were then retrieved by patient IDs and the filtered component IDs; 5) Missing, erroneous, and duplicated records were removed, and the remaining records were sorted by date and transformed into time series format for each patient.
Data Standardization to SNOMED-CT
Using SNOMED-CT ontology as the mapping standard, we successfully mapped 22,842 out of the 39,570 unique clinical concepts. These 22,842 concepts were mapped to 4,673 unique SNOMED-CT concepts. Table 2 shows the number of unique concepts before mapping, with available mapping, and the number of SNOMED-CT concepts mapped to. Through this process, we significantly reduced the feature dimension, removed data redundancy and inconsistency, and lowered the likelihood of data collinearity. 
Patients with Chronic Kidney Disease (CKD)
Kidney is an important organ of human bodyfiltering blood, removing waste, balancing fluid, and controlling the level of electrolytes. Chronic Kidney Disease (CKD) is becoming more prevalent at a rapid speed around the world. CKD can be divided into 5 stages based on estimated glomerular filtration rate (eGFR) measurement. Early diagnosis of CKD prevents patients from regressing into late-stage CKD which causes serious complications. Late-stage CKD can lead to end-stage renal disease (ESRD) and cardiovascular disease (CVD), which steeply increase patient pain and economic burden. However, the gradual loss of kidney function is difficult to diagnose due to the absence of direct evidence from clinical trials (Moyer, 2012) . Hence frequent and regular measure of serum creatinine-used to calculate eGFR-is essential for evaluating changes in renal functions. Identifying trends in eGFR is more important than one-off readings, as suggested by the Renal Association, "a progressive fall in eGFR across serial measurements is more concerning than stable readings which don't change over time" (2019) .
EHR provides a possibility for health care organization to monitor and identify early-stage CKD. Lenart et al. developed clustering techniques to detect progression of CKD (Lenart et al., 2016) . Kmedoids clustering was applied on patients' routine measurements and lab tests such as blood pressure, body mass index, Hemoglobin A1c (HbAlc), triglycerides and high-density lipid cholesterol (Lenart et al., 2016) . The Cluster Progression Score (CPS) was designed to measure patients' relative health status (Lenart et al., 2016) . This clustering process can help health care organization detect early stage CKD by monitoring the recorded lab measurements.
Information Extraction from EPIC EHR Database
The extracted dataset covers 33,303 patients with the ICD-9 code starting with "585" or ICD-10 code starting with "N18", both referring to "Chronic Kidney Disease". This dataset spans the years 1997-2018 and is composed of patient-level data (24Mb), problem lists (288Mb), medications (6.74Gb), billing (1.90Gb), laboratory orders (8.66Gb), and clinical notes (18.55 Gb), totalling 36.16 Gigabytes. Patient IDs were successfully encrypted using SHA-256 encryption. PHI including patient names, addresses, institutions, age, phone numbers, and email addresses were detected and encrypted into dummy tokens. Patient eGFR laboratory test results were used as indications of disease progression. eGFR records were retrieved by the following method: 1) component IDs for lab records matching the query string "%eGFR%" or "%GLOMERULAR FILTRATION RATE%" were retrieved; 2) Irrelevant lab components were discarded, leaving 16 unique component IDs. We then examined eGFR records matching these component IDs and found that only records corresponding to two component IDs "12122727" and "12122728" were well-maintained.
3) eGFR lab records are then retrieved by patient IDs and these two component IDs. 4) Missing, erroneous, and duplicated records were removed, and the remaining records were sorted by date and transformed into time series format for each patient.
Patients with Cardiovascular Disease (CVD)
The CCI-health database (Lee et al., 2016) contains 37,742 patients with CVD from 737 clinical sites. Processing through the pipeline, each patient is finally characterized by 11 raw features including demographics, treatment duration, and co-existing conditions, and 1,757 standardized features in SNOMED-CT terminology including laboratory tests, diagnosed problems, and medications. For each patient, treatment duration is determined by calculating the elapsed time between diagnosis (indicated by the first prescription of a medication) and the last recorded activity (i.e. procedure, lab, etc.). Measurements of lipids and lipoproteins are processed into time series, since these are closely related to cardiovascular conditions and can potentially be used to characterize the severity of CVD. Lack of high-density lipoproteins (HDL) is significantly associated with the development of coronary heart disease (Gordon et al., 1977) . In contrast, low-density lipoprotein increases the risk of heart disease and is considered a "bad" cholesterol (Gordon et al., 1977) . Triglyceride is also associated with incidence of heart disease but has a less significant effect (Gordon et al., 1977) .
Multivariate Time Series Clustering to Characterize CVD Treatment Outcome
In the analysis, we use HDL and LDL measurements to form an MTS containing two time series for each patient for clustering. Each of these time series were resampled to quarterly frequency (one measurement every three months). Gaps in the data were filled by propagating the non-NaN values forward first, and then backward along a series. For each of the three types of laboratory measurements, we removed patients with less than 6 raw measurements or less than 8 resampled measurements. This produces a data set containing 3,155 remaining patients. The distance between each pair of corresponding time series was calculated using GAK, DTW, and soft-DTW distances in three separate experiments. Distances between each pair of MTS was then obtained by aggregating the two distances between each pair of corresponding univariate time series using weighted average, where the weight of LDL measurements was 0.7 and the weight of HDL measurements was 0.3. A higher weight was assigned to LDL measurements because LDL is generally considered a stronger risk factor for CVD than HDL (Badimon and Vilahur, 2012) . K-medoids clustering was performed on the final distance matrix, partitioning the patients into K groups. Here, we set K=2 and K=3 for each set of experiments. When K>3, the clusters are overpartitioned. The quality of clusters is evaluated both visually and quantitatively. Visually, trends of laboratory measurements are shown with boxplots of each patient's measurement taken at each time point. Quantitatively, the following statistics are calculated for each cluster: 1) median of first measured value; 2) median of the last measured value; 3) difference between the two medians. Since the goal is to segregate patients with different treatment outcomes, ideal clusters of patients should exhibit different trends of lab measurements. Figures 3-4 show the boxplots of aggregated laboratory measurements by clusters. Tables 3-4 list the per-cluster statistics. Results are shown for K=2 and K=3, and for all distance metrics used. Ideally, clusters of patients showing 1) high HDL measurements, 2) low LDL measurements, 3) an upward trend in HDL progression, and 4) a downward trend in LDL progression should be characterized as having satisfactory treatment outcome. By comparing the trend of laboratory progressions and the summary statistics, we found that when using the GAK distance metric and setting K=2, we obtain the clusters that best characterize two patient groups with distinct outcomes. Cluster 1 satisfies all four characteristics of good outcome listed above, whereas patients in Cluster 2 show opposite characteristics except also a downward trend in LDL progression, with the end median value slightly above that of Cluster 1. When using other metrics and K, clusters are not as wellpartitioned (i.e. soft-DTW, K=2), or patients within the same cluster exhibit trends in HDL and LDL progression that define opposite qualities of treatment outcomes (i.e. DTW, K=3). Complete clustering analysis are presented in Lee et al. (2019) . Furthermore, machine learning results confirm that this clustering approach produces promising partitions. Specifically, the groups are classified with unbiased10-fold cross validation accuracy of 85-91%, and 83-93% blind prediction accuracy on independent sets of patients. We will continue to investigate more robust approaches to adapt to the different types of diseases and patterns.
CONCLUSIONS
In this paper, we designed a comprehensive information extraction and pre-processing pipeline for EPIC-based EHR system. This pipeline consists of information extraction, de-identification and encryption, standardization, and time series processing and clustering. We applied this pipeline to three cohorts of patientsthose with prostate cancer, chronic kidney diseases, and cardiovascular diseases, and prepared tabularized data files with standardized terminologies and reduced feature dimensions. These data files can be input into machine learning algorithms for further knowledge discovery.
Using longitudinal laboratory records measured during care delivery, we have also uncovered patient subgroups with different outcomes. We introduced an approach to cluster irregular MTS by aggregating distances between univariate time series. This allows us to utilize multiple types of laboratory records for each patient to characterize treatment outcome. Among the distance metrics used, GAK produced the best clusters.
The computational pipeline can be adapted to similar large EHR systems and datasets and for other patient cohorts. These modifications include: 1) redesigning SQL queries by modifying diagnosis codes when extracting patient ID list to accommodate different target cohorts; 2) modifying SQL queries to extract additional data from target disease-specific tables; 3) reidentifying new motifs through expert recommendation and/or manual exploration of freetext data and redesigning new regular expressions for pattern-based feature extraction.
Through the design and implementation of this pipeline, we have tackled some major big data challenges including volume, variety, veracity, and especially value. This results in a highly robust, efficient, and customizable pipeline that can be easily applied to current EHR databases to fulfil their potential in both academic and clinical research.
Future works remains in the search of more robust and systematic methods for evaluating the quality of time series clusters. Given the complexity of irregular MTS and the difficulty involved in labelling clusters, it is necessary to combine effective visualization techniques with quantitative measures to achieve this task. Machine learning analysis can help to quantify the separation performance of the clustering results. Beyond the EHR data, there is also an opportunity to combine the EHR data with other types of OMICs data obtained from outside laboratory tests which are currently not recorded within the EHR systems.
